TrialEuropean journal of neurology2023

Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.

Rosa Cortese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.